(866) 280-3417 Call for Free Case Review
Select Page

ExjadeExjade (deferasirox) was approved through the FDA’s accelerated approval program in 2005 as a drug meant to treat chronic iron overload developed by multiple long-term blood transfusions.

However, since being brought to market, Exjade has been tied to controversy following the discovery of several notable health complications. These previously undisclosed or understated complications include:

  • Renal impairment
  • Hepatic impairment
  • Gastrointestinal hemorrhage
  • Gastrointestinal ulceration
  • Gastrointestinal perforation
  • Severe skin rash/reaction
  • Stevens-Johnson Syndrome (SJS)
  • Toxic Epidermal Necrolysis (TEX)

Are There Exjade Class Action Lawsuits?

Currently, a class action lawsuit against Exjade manufacturer, Novartis Pharmaceuticals, has yet to be formed.

However, this is due to the recent filing nature of many Exjade dangerous drug lawsuits. Victims filing lawsuits against Novartis Pharmaceuticals began in late 2015, meaning many are classified as pending legal action with potentially hundreds more not yet at filing stages.

As more Exjade victims come forward and file lawsuits against Novartis, the ability to create a class action lawsuit will increase. Several manufacturers of drugs with similar magnitude have been faced with class action lawsuits, meaning that precedent would indicate an future Exjade class action lawsuit as likely.

The future development of a class action lawsuit against Novartis will offer plaintiffs a greater ability to pursue a legal action suitable to their needs as well as – at times – increase their chances of receiving an appropriate settlement offer.

Can I Join A Exjade Class Action Lawsuit?

In order to be eligible to join an Exjade class action lawsuit when one develops, you must file an Exjade dangerous drug lawsuit immediately.

Criteria to join a potential class action lawsuit are similar to those used to determine if you can file a standalone lawsuit. Therefore, if you are approved to file a lawsuit against Novartis Pharmaceuticals, you will likely have the ability to join an Exjade class action lawsuit soon after it is created.

In order to meet the criteria to file a Exjade lawsuit, you or a loved one must have experienced a requirement point within 48 hours of using the drug. The requirements that must be met include:

  • Death
  • Gastrointestinal ulceration
  • Gastrointestinal hemmorrhage
  • Gastrointestinal perforation
  • Severe skin rash/reaction
  • Stevens-Johnson Syndrome (SJS)
  • Toxic Epidermal Necrolysis (TEN)
  • Erythema Multiforme

Having a skilled and experienced attorney at your disposal is the most important factor in retaining the highest chance of joining a future Exjade class action lawsuit. Such an attorney will be able to guide you through all the legal hurdles and necessary actions that come prior to filing a standalone lawsuit and subsequently joining a class action lawsuit.

Our Exjade Gastrointestinal Complication Case Lawyers Can Help

Our dangerous drug attorneys can help you if someone you love has been diagnosed with pancreatic cancer after taking Exjade. Lawsuits are expected to be filed against the makers of this medication. You may be entitled to a settlement.

Our No-Fee Promise on Exjade Cases

You can afford to have our great team of Exjade lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive an Exjade settlement
  • Phone calls are always free

Start Your Exjade Claim

Our Exjade dangerous drug lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-4722 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing Exjade lawsuit claims.

  • Was this information helpful?
  • Yes   No